Roxolid® SLActive®

Advanced biocompatibility.

New research shows SLActive® surface stimulates an early anti-inflammatory cell response compared to non SLActive surface as measured in vitro as a reduction in pro inflammatory markers* and an increase in anti-inflammatory** markers.31​

SLActive® is associated with an increased anti-inflammatory macrophage response in the early healing phase in both healthy and diabetic animals. This may be an important mechanism to improve osseous healing under compromised systemic conditions.21​ 

*Il1b, Il6, Tnfa, IL-1beta, IL-6, TNF-alpha, (pro-inflammatory)​
**Il10, Tgfb1, Chil3, Rentla, IL-4, IL-10 (anti-inflammatory)

New data on the SLActive®’s anti-inflammatory cell response has been presented at the 95th General Session of International Association for Dental Research, US.

Any questions? Contact us.

Data usage agreement*

Read our privacy nolicy.

Please retype the code above